InformedDNA

Convenient telegenetic counseling services provided by board-certified and licensed genetic counselors, supporting patients through pre- and post-test counseling, test facilitation, and result interpretation.

Specialty-specific risk assessment tools designed to help determine if a genetics evaluation is recommended for a patient.

A pharmacogenomics-based personalized medication management program that utilizes DNA analysis to help providers tailor treatments to an individual’s unique genetic makeup, lifestyle, and medical conditions.

Expert telehealth genetic counseling appointments with fully licensed, board-certified genetics experts across all subspecialties, providing patient care, guidance, and risk assessment.

A genetic-focused clinical trial recruitment and engagement service designed to accelerate eligible patient enrollment and enhance retention through expert screening, genetic testing, and telehealth genetic counseling.

Provides comprehensive, clinically-relevant, and scientifically-rigorous results for pharmacogenomic and medication safety reporting.

Provides recommendations for, and against, specific ADHD medications based on the patient’s DNA.

Tackles medication safety, efficacy, and Opioid Use Disorder predilection in an actionable report that determines the most appropriate pain medication based on an individual’s DNA.

Based on an individual’s pharmacogenomics profile, this report provides details for the treatment of depression, anxiety, ADHD, and other psychiatric health concerns.

Comprehensive analysis of risks associated with polypharmacy in the cardiac patient include drug-drug interactions, anticholinergic burden, age- and pregnancy-related concerns, FDA warnings, food and drink interactions, and genetics.

Details the diagnosis and lists medications to avoid. Available alone or as part of the Perioperative Medication Appropriateness Report.

Evaluates and provides insights on hard-to-manage wounds prevalent among elderly and diabetic patients.

Diagnoses multiple respiratory ailments including SARS, pneumonia, and TB from a single sample.

Provides identification of pathogenic organisms to guide rapid therapeutic decisions.

Provides differential diagnoses of Bacterial Vaginosis (BV), Yeast Infection, and Trichomoniasis (Trich) Infections with increased specificity and sensitivity, alongside treatment options.

Provides detailed infection confirmation to guide rapid therapeutic decisions.

Enhances diagnostic accuracy and supports effective therapeutic decision-making for conditions such as gastroenteritis, food poisoning, and other GI-related ailments.